MSI Financial Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

MSI Financial Services’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$63K	Sell	759 -1,553	-67%	-$134K	﹤0.01%	1735
2016 Q3	$214K	Buy	2,312 +1,268	+121%	+$119K	0.01%	1021
2016 Q2	$81K	Sell	1,044 -353	-25%	-$30K	﹤0.01%	1516
2016 Q1	$115K	Buy	1,397 +981	+236%	+$79.8K	﹤0.01%	1260
2015 Q4	$44K	Buy	416 +116	+39%	+$12.1K	﹤0.01%	1792
2015 Q3	$32K	Hold	300	–	–	﹤0.01%	1441
2015 Q2	$41K	Hold	300	–	–	﹤0.01%	1411
2015 Q1	$37K	Sell	300 -100	-25%	-$10.6K	﹤0.01%	1462
2014 Q4	$36K	Hold	400	–	–	﹤0.01%	1220
2014 Q3	$29K	Sell	400 -96	-19%	-$6.31K	﹤0.01%	1331
2014 Q2	$31K	Buy	496 +196	+65%	+$11.8K	﹤0.01%	1304
2014 Q1	$20K	Hold	300	–	–	﹤0.01%	1427
2013 Q4	$21K	Hold	300	–	–	﹤0.01%	1367
2013 Q3	$22K	Hold	300	–	–	﹤0.01%	1171
2013 Q2	$17K	Buy	+300	New	+$18.7K	﹤0.01%	1308

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MSI Financial Services's BMRN Position: Q4 2016 in Review

MSI Financial Services reduced its BioMarin Pharmaceuticals (BMRN) stake by 67% in Q4 2016, selling an estimated $134K and leaving 759 shares worth $63K. The position accounts for ﹤0.01% of the portfolio, ranked #1735.

MSI Financial Services first reported a position in BMRN in Q2 2013 and has held it in 15 quarters since. The position peaked at $214K in Q3 2016. 415 funds tracked by Wall St. Rank hold BMRN as of Q4 2016.

MSI Financial Services held 759 shares of BioMarin Pharmaceuticals worth $63K as of Q4 2016.
MSI Financial Services sold 1,553 BioMarin Pharmaceuticals shares in Q4 2016, an estimated $134K.
BioMarin Pharmaceuticals made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #1735 holding.
MSI Financial Services first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
MSI Financial Services's BioMarin Pharmaceuticals position peaked at $214K in Q3 2016.
415 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.